GRG's Center For Experiential Learning

Metastatic melanoma was once a near-certain death sentence, but PD-1/PD-L1 inhibitors have rewritten the story. From survival rates once measured in months to long-term remission and renewed hope, immune checkpoint therapies like nivolumab and pembrolizumab are transforming cancer care and reshaping the future of oncology.

Emerging therapies like complement and FcRn inhibitors are reshaping Myasthenia Gravis care, offering more targeted and effective options for patients. But with challenges in diagnosis, access, and long-term safety still in play, the road ahead demands innovation, collaboration, and a patient-centered approach.

Discover how Cryoneurolysis is transforming pain management, offering targeted, drug-free, non-surgical relief for chronic and post-operative pain, with minimal downtime and lasting results.

The U.S. generic injectables market is expanding fast but so are drug shortages. Based on insights from 300 pharmacy directors, this blog unpacks the real issues behind the supply strain and what healthcare leaders say needs to change.

In a world where proactive health management is becoming increasingly vital, continuous health monitoring devices—especially smartwatches...

The healthcare sector is increasingly adopting artificial intelligence (AI) and machine learning (ML) to streamline processes, improve...